These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 12118567)

  • 21. A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Ringdén O; Labopin M; Tura S; Arcese W; Iriondo A; Zittoun R; Sierra J; Gorin NC
    Br J Haematol; 1996 Jun; 93(3):637-45. PubMed ID: 8652385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term salivary function after conditioning with busulfan, fractionated or single-dose TBI.
    Garming-Legert K; Remberger M; Ringdén O; Hassan M; Dahllöf G
    Oral Dis; 2011 Oct; 17(7):670-6. PubMed ID: 21718391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autologous bone marrow transplantation in acute myeloid leukemia: the University of Minnesota experience.
    Dusenbery KE; Steinbuch M; McGlave PB; Ramsay NK; Blazar BR; Neglia JP; Litz C; Kersey JH; Woods WG
    Int J Radiat Oncol Biol Phys; 1996 Sep; 36(2):335-43. PubMed ID: 8892457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fractionated total body irradiation in marrow transplantation for leukaemia.
    Vitale V; Bacigalupo A; Van Lint MT; Frassoni F; Ricci G; Siracusa G; Marziano G; Vitali ML; Scielzo G; Tomassini A
    Br J Haematol; 1983 Nov; 55(3):547-54. PubMed ID: 6357268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulmonary complications of bone marrow transplantation: a comparison of total body irradiation and cyclophosphamide to busulfan and cyclophosphamide.
    Hartsell WF; Czyzewski EA; Ghalie R; Kaizer H
    Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):69-73. PubMed ID: 7536723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single-Dose Daily Fractionation Is Not Inferior to Twice-a-Day Fractionated Total-Body Irradiation Before Allogeneic Stem Cell Transplantation for Acute Leukemia: A Useful Practice Simplification Resulting From the SARASIN Study.
    Belkacemi Y; Labopin M; Giebel S; Loganadane G; Miszczyk L; Michallet M; Socié G; Schaap NPM; Cornelissen JJ; Yakoub-Agha I; Polge E; Mohty M; Gorin NC; Nagler A;
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(3):515-526. PubMed ID: 29928948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Consequences of two different doses to the lungs during a single dose of total body irradiation: results of a randomized study on 85 patients.
    Girinsky T; Socie G; Ammarguellat H; Cosset JM; Briot E; Bridier A; Gluckman E
    Int J Radiat Oncol Biol Phys; 1994 Nov; 30(4):821-4. PubMed ID: 7960983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Busulfan, cyclophosphamide and total body irradiation as conditioning for allogeneic bone marrow transplantation for acute and chronic myeloid leukemia.
    Hirabayashi N; Goto S; Ishii M; Yuge M; Mitsuma A; Noda N
    Bone Marrow Transplant; 1998 Jun; 21(11):1079-83. PubMed ID: 9645568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of fractionated total body irradiation and dose rate on cataractogenesis in bone marrow transplantation.
    Beyzadeoglu M; Dirican B; Oysul K; Arpaci F; Pak Y
    Haematologia (Budap); 2002; 32(1):25-30. PubMed ID: 12243552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose escalation of total marrow irradiation with concurrent chemotherapy in patients with advanced acute leukemia undergoing allogeneic hematopoietic cell transplantation.
    Wong JY; Forman S; Somlo G; Rosenthal J; Liu A; Schultheiss T; Radany E; Palmer J; Stein A
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):148-56. PubMed ID: 22592050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extramedullary relapse following total marrow and lymphoid irradiation in patients undergoing allogeneic hematopoietic cell transplantation.
    Kim JH; Stein A; Tsai N; Schultheiss TE; Palmer J; Liu A; Rosenthal J; Forman SJ; Wong JY
    Int J Radiat Oncol Biol Phys; 2014 May; 89(1):75-81. PubMed ID: 24725691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Total-body irradiation and cataract incidence: a randomized comparison of two instantaneous dose rates.
    Ozsahin M; Belkacemi Y; Pene F; Dominique C; Schwartz LH; Uzal C; Lefkopoulos D; Gindrey-Vie B; Vitu-Loas L; Touboul E
    Int J Radiat Oncol Biol Phys; 1994 Jan; 28(2):343-7. PubMed ID: 8276648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allogeneic marrow transplantation following cyclophosphamide and escalating doses of hyperfractionated total body irradiation in patients with advanced lymphoid malignancies: a Phase I/II trial.
    Demirer T; Petersen FB; Appelbaum FR; Barnett TA; Sanders J; Deeg HJ; Storb R; Doney K; Bensinger WI; Shannon-Dorcy K
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):1103-9. PubMed ID: 7607931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lethal pulmonary complications significantly correlate with individually assessed mean lung dose in patients with hematologic malignancies treated with total body irradiation.
    Della Volpe A; Ferreri AJ; Annaloro C; Mangili P; Rosso A; Calandrino R; Villa E; Lambertenghi-Deliliers G; Fiorino C
    Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):483-8. PubMed ID: 11872296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
    Mengarelli A; Iori A; Guglielmi C; Romano A; Cerretti R; Torromeo C; Micozzi A; Fenu S; Laurenti L; Donato V; De Felice L; Arcese W
    Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 20 years of experience in static intensity-modulated total-body irradiation and lung toxicity. Results in 257 consecutive patients.
    Schneider RA; Schultze J; Jensen JM; Hebbinghaus D; Galalae R; Kimmig BN
    Strahlenther Onkol; 2007 Oct; 183(10):545-51. PubMed ID: 17896085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allogeneic bone marrow transplantation for chronic myeloid leukemia: a retrospective study of busulfan-cytoxan versus total body irradiation-cytoxan as preparative regimen in Koreans.
    Kim I; Park S; Kim BK; Chang HM; Bang SM; Byun JH; Kim DJ; Min WS; Kim HJ; Kim CC
    Clin Transplant; 2001 Jun; 15(3):167-72. PubMed ID: 11389706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cataract-free interval and severity of cataract after total body irradiation and bone marrow transplantation: influence of treatment parameters.
    van Kempen-Harteveld ML; Struikmans H; Kal HB; van der Tweel I; Mourits MP; Verdonck LF; Schipper J; Battermann JJ
    Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):807-15. PubMed ID: 11020578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autologous bone marrow transplantation for haematological malignancies--experiences of the centre of Zagreb.
    Nemet D; Labar B; Bogdanic V; Skodlar J; Petrovecki M; Mrsic M; Maravic N; Sneller V; Radman I; Kovacevic-Metelko J
    Wien Med Wochenschr; 1995; 145(2-3):61-4. PubMed ID: 7762256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies.
    Socié G; Clift RA; Blaise D; Devergie A; Ringden O; Martin PJ; Remberger M; Deeg HJ; Ruutu T; Michallet M; Sullivan KM; Chevret S
    Blood; 2001 Dec; 98(13):3569-74. PubMed ID: 11739158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.